CDC’s stance following inquiry into TB-infected bone grafts
The U.S. Centers for Disease Control and Prevention (CDC) is calling for improved donor screening and testing capping its investigation into bone graft materials infected
The U.S. Centers for Disease Control and Prevention (CDC) is calling for improved donor screening and testing capping its investigation into bone graft materials infected
Mandible reconstruction goes far beyond the mere removal of a tumor; it’s about restoring a patient’s quality of life and their ability to interact with

INTRODUCTION Traumatic ulcerative granuloma with stromal eosinophilia (TUGSE) is a relatively rare, benign granulomatous ulcerative oral mucosal lesion. TUGSE occurs more commonly among women compared
Bone graft materials infected with tuberculosis (TB) that were used in three dozen dental and medical procedures have led to a second patient’s death, triggering
The U.S. National Institute on Aging of the National Institutes of Health (NIH) has awarded a New York University (NYU) College of Dentistry researcher a
A new study published in the Proceedings of the National Academy of Sciences (November 17, 2014) has found that, after long-term exposure, triclosan can cause
Scientists have used an experimental drug produced from the seeds of an Australian rainforest plant to kill head and neck tumors, as well as melanomas,
In patients with advanced esophageal cancer, radiation therapy (RT) alone is as effective as RT combined with chemotherapy in decreasing swallowing complications, thus allowing patients
A blood test may be beneficial in indicating neoadjuvant treatment regimens for patients with esophageal squamous cell carcinoma (ESCC), according to research presented at this
Each year, thousands of babies are born in the U.S. with craniofacial defects, from cleft lips and palates to more severe abnormalities of the face
Researchers have hijacked a defense system normally used by bacteria to fend off viral infections and redirected it against human papillomavirus (HPV), the virus that
Previous research has shown that high death rates among head and neck cancer (HNC) patients usually occur only when mutations in the tumor-suppressor gene coincide